NCT02710513

Brief Summary

The purpose of this study is to evaluate the healthy properties of a dietary intervention based on an innovative pasta enriched with prebiotic fibers (barley beta-glucans). The hypothesis is that the gut microbiota and metabolome, the nutritional status, the redox/subclinical inflammation parameters and the markers of cardiovascular risk may improve in healthy subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 16, 2016

Completed
Last Updated

March 17, 2016

Status Verified

March 1, 2016

Enrollment Period

4 months

First QC Date

March 7, 2016

Last Update Submit

March 16, 2016

Conditions

Keywords

beta-glucansgut microbiotap-cresyl sulphate (pCS)indoxyl sulphate (IS)short-chain fatty acid (SCFA)

Outcome Measures

Primary Outcomes (1)

  • Reduction in non-HDL cholesterol

    Confirmation of beta-glucans properties in reduction of total and LDL cholesterol

    at the end of the intervention period (2 months)

Secondary Outcomes (4)

  • Effects on gut microbiota SCFA modulation

    at the end of the intervention period (2 months)

  • Effects on gut microbiota pCS modulation

    at the end of the intervention period (2 months)

  • Effects on gut microbiota IS modulation

    at the end of the intervention period (2 months)

  • Effects on Flow-mediated dilation (FMD)

    at the end of the intervention period (2 months)

Study Arms (1)

Beta-glucans

EXPERIMENTAL

2 months run-in period (Mediterranean Diet-based dietary scheme including a daily supply of 100 g of normal pasta) + 2 months intervention period (Mediterranean Diet-based dietary scheme including a daily supply of 100 g of functional pasta providing 3 g of beta-glucans/day)

Dietary Supplement: Beta-glucans

Interventions

Beta-glucansDIETARY_SUPPLEMENT

2 months Mediterranean Diet-based free diet (run-in) + 2 months Mediterranean Diet-based free diet with a daily supplementation of 100 g of beta-glucans pasta (intervention). Medical visits, dietary counselling with food frequency questionnaires administration, blood, urine and feces collection were performed before (T0) and after (T2) the two months of beta-glucans intervention.

Also known as: Functional pasta enriched with barley beta-glucans
Beta-glucans

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy subjects
  • aged between 30 and 70 years
  • BMI between 18.5 and 24.9
  • omnivorous diet
  • informed consent signed

You may not qualify if:

  • diabetes type 2
  • urine protein \> 1g/24h
  • antibiotics and probiotics administration by 15 days before the enrollment
  • gastrointestinal, celiac, inflammatory systemic and chronic liver diseases
  • recent diagnosis of cancer
  • corticosteroid or immunosuppressive therapies
  • previous major acute cardiovascular pathologies (heart attack, cerebral ictus)
  • hyperlipidemia
  • consume of alcohol
  • psychiatric diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOUC "Policlinico"

Bari, 70124, Italy

Location

MeSH Terms

Interventions

beta-Glucans

Intervention Hierarchy (Ancestors)

GlucansPolysaccharidesCarbohydrates

Study Officials

  • Loreto Gesualdo, MD Full Prof

    Head of the Nephrology, Dialysis and Transplantation Unit "Aldo Moro" University of Bari Azienda Ospedaliero-Universitaria Consorziale "Policlinico"

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2016

First Posted

March 16, 2016

Study Start

December 1, 2014

Primary Completion

April 1, 2015

Study Completion

June 1, 2015

Last Updated

March 17, 2016

Record last verified: 2016-03

Locations